European Medicines Agency post-authorisation procedural advice for users of the centralised procedure: document with tracked changes
European Medicines Agency post-authorisation procedural advice for users of the centralised procedure
Expected publication dates of PRAC recommendations on safety signals
Human medicines European public assessment report (EPAR): Hympavzi, marstacimab, Date of authorisation: 18/11/2024, Revision: 2, Status: Authorised
Withdrawn application: Vectra 3D, 27/11/2024
Human medicines European public assessment report (EPAR): Hydrocortisone Aguettant, Status: Application withdrawn
2009 (H1N1) influenza pandemic
Pandemic influenza
Vaccines for pandemic influenza
Human medicines European public assessment report (EPAR): Refixia, nonacog beta pegol, Date of authorisation: 02/06/2017, Revision: 8, Status: Authorised